Kidney Trouble Short-Lived in Most Liver Transplan...(12 weeks before transplant the presence ...),Health
Navigation Links
Kidney Trouble Short-Lived in Most Liver Transplant Patients
Date:5/6/2008
12 weeks before transplant, the presence of diabetes, and the serum creatinine value at the time of transplant could help identify patients who might be considered for combined liver-kidney transplantation.
The study was published in the May issue of Liver Transplantation.
More information
The American Liver Foundation has more about liver transplantation.
-- Robert Preidt
SOURCE: Liver Transplantation, news release, April 30, 2008
'/>"/>
| Copyright©2008 ScoutNews,LLC. All rights reserved |
Related medicine news :
1. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
2. Expenses Overshadow Optimism for Kidney Failure Patients
3. Katie Lee Joel to Conduct Cooking Demonstration for Local Patients With Chronic Kidney Disease
4. Lowering Blood Protein Wont Help Kidney Patients
5. DaVita Teammates Bicycling 230 Miles for Kidney Disease Education
6. Stem Cell Therapy Disappoints Against Rare Kidney Ailment
7. Metabolic syndrome heightens risk for development of uric-acid kidney stones
8. Nighttime Home Dialysis a Boon for Kidney Patients
9. New Survey Reveals Kidney Patients Concern About Medicare Policies
10. Nations Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care
11. Kidney Awareness Time (KAT) Walk Raised Awareness and $400,000 for Kidney Education and Prevention Programs
Post Your Comments:
(Date:11/21/2008)...tCall/ -- Heska Corporation,(Nasdaq: HSKA ) tod...ty of,Security Analysts, 12th Annual Biotech and ...t 1177 Avenue of the Americas, 2nd Floor in New Yo... 9:35 a.m. Eastern Time (7:35 a.m.,Mountain Time)...o weeks,following the presentation through a link...
(Date:11/21/2008)...inst Lennox-Gastaut syndrome , , FRIDAY,...zel (rufinamide) has been approved as a supplement... Lennox-Gastaut syndrome, the U.S. Food and Drug A...was based on results of a four-month clinical tria... patients who took a placebo, those who took the d...
(Date:11/21/2008)...singCenter.com, the premier site,for online nursi... has been,updated to improve the interactive expe...by Lippincott Williams & Wilkins (LWW), Nursin...ontinuing education activities and free,access to... journals.,Lippincott Williams & Wilkins is a...
(Date:11/21/2008)...-FirstCall/ -- Today, prescription drugs are the f...8 percent of patients suffering chronic conditions...ic condition account for 96 percent of all prescri...costs. A proprietary new pharmacy model developed...(NYSE: MHS ) significantly reduces critical gaps...
Breaking Medicine News(10 mins):Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6[0] Heska to Present at New York Society of Security Analysts' 12th Annual Biotech and Specialty Pharma Conference[0] FDA Approves New Drug for Severe Epilepsy[0] NursingCenter.com Launches New Features to Improve User Experience[0] New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
...n the New England Journal of Medicine suggested th...disease in some individuals. The study was conduct... who included// dentists, veterinarians, optometri... 40 to 75 years. The study focused on the relation...
...red in the clinical journal of Ophthalmology concl...with a five-year risk of ocular hypertension, and ... increased prevalence// of glaucoma, in Caucasians...ipants, aged between 43 to 84, who received baseli...
...y the Cancer and Leukemia Group B (CALGB) and pres... Symposium assessed the effectiveness of reducing ...y used chemotherapy regimen to improve survival ra...ducted as follow-up of a mathematical model which ...
...een associated to many risk factors like age, horm... alcohol consumption. Several earlier studies have... been consistent// and also because smoking often ...e not been sure that alcohol was the most importan...
Other Medicine News:Health News:Survival rates in breast cancer patients improved with "Dose Dense Chemotherapy" 2(Date:11/20/2008)...- The following is being released by Center for He... AIDS Day Audio Media Conference , , WHEN.... EST , Call-in number: 1-800-949-8476 , RSV.../1xe41i2yre8rs , , WHY: With new HIV inf...n treatment worldwide, advocates are calling on th...
(Date:11/20/2008)...lk. It does a body good. And,now it,s doing it ev...,research, scientists at OncoNutrition(TM) have di...ate the body,s own production of antioxidants. , ...to:, http://www.prnewswire.com/mnr/eqwestgroup/361...apies, the chief scientist, Dr. David,Tsai, disco...
(Date:11/20/2008)...EXEL International Corporation (Nasdaq: PRXL ), ...er, today announced that it has opened an office i...clinical research capabilities. With the addition ...ughout five important biopharmaceutical centers in...il, Chile, and Mexico. This expansion further stre...
(Date:11/19/2008)...critical enzyme,s regulation may hold key to under... , , MEMPHIS, Tenn., Nov. 19 /PRNewswire-US...search Hospital have gained new insights into regu...ed calpains. , , As the cell,s molecular o...rocesses, including the movement of cells in tissu...
Breaking Medicine Technology:Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program 2018 1Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program 2018 2Actress Colleen Zenk Pinter Partners with the Oral Cancer Foundation to Raise Public Awareness 7269 1Actress Colleen Zenk Pinter Partners with the Oral Cancer Foundation to Raise Public Awareness 7269 2Actress Colleen Zenk Pinter Partners with the Oral Cancer Foundation to Raise Public Awareness 7269 3The World Economic Forum Announces Technology Pioneers 2008 3A Mondobiotech Selected 2016 1The World Economic Forum Announces Technology Pioneers 2008 3A Mondobiotech Selected 2016 2The World Economic Forum Announces Technology Pioneers 2008 3A Mondobiotech Selected 2016 3The World Economic Forum Announces Technology Pioneers 2008 3A Mondobiotech Selected 2016 4Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline 7266 1Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline 7266 2Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline 7266 3Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline 7266 4[0] Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts[0] Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects[0] PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru[0] New Insight Into the Controls on a Go-To Enzyme
...prised of triglycerides and cholesterols, vary wit...l activity. All of these factors contribute to ser...correlate with risk of untoward vascular and cardi...dical laboratory values are so much in the public ...terol, making the discussion of plasma lipid test ...
...mbin levels is necessary to plan or evaluate antic...nditions, such as hyperhomocystinemia, elevated fa...ficiency and disorders of plasmin generation, and ...postoperative state, antiphospholipid syndrome, hy...s are also monitored along with other tests (such ...
Other Medicine Technology:Analyzers Offer Point-of-Care Lipid Panels 2Analyzers Offer Point-of-Care Lipid Panels 3Prothrombin Time Comes in Small (CLIA-Waived) Packages 2Prothrombin Time Comes in Small (CLIA-Waived) Packages 3...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products:| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |